Quantitative Proteomic Profiling Identifies SOX8 as Novel Regulator of Drug Resistance in Gestational Trophoblastic Neoplasia
The development of drug resistance remains one of the major challenges to current chemotherapeutic regimens in gestational trophoblastic neoplasia (GTN). Further understanding on the mechanisms of drug resistance would help to develop more effective therapy to treat GTN. Herein, tandem mass tag-base...
Main Authors: | Fu Jun, Zheng Peng, Yi Zhang, Dazun Shi |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-04-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fonc.2020.00557/full |
Similar Items
-
DPP4 Regulates DHCR24-Mediated Cholesterol Biosynthesis to Promote Methotrexate Resistance in Gestational Trophoblastic Neoplastic Cells
by: Weijie Yuan, et al.
Published: (2021-12-01) -
A review on management of gestational trophoblastic neoplasia
by: Seyedeh Reyhaneh Yousefi Sharami, et al.
Published: (2020-01-01) -
Spontaneous regression of gestational trophoblastic neoplasia
by: Kaoru Niimi, et al.
Published: (2017-08-01) -
Rescoring of Patients with Gestational Trophoblastic Neoplasia Using Modified Scoring System By Figo
by: Taner Turan, et al.
Published: (2006-12-01) -
Radiographically occult pulmonary metastases from gestational trophoblastic neoplasia
by: Tina Hong, MD, et al.
Published: (2017-06-01)